Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
LAMIVUDINE
AURO PHARMA INC
J05AF05
LAMIVUDINE
300MG
TABLET
LAMIVUDINE 300MG
ORAL
30/60/100/500
Prescription
NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS
Active ingredient group (AIG) number: 0128157005; AHFS:
CANCELLED POST MARKET
2013-10-16
_Page 1 of 42 _ PRODUCT MONOGRAPH PR AURO-LAMIVUDINE lamivudine 150 mg & 300 mg tablets AUROBINDO STANDARD Antiretroviral Agent AURO PHARMA INC. Date of Revision: 3700 Steeles Avenue West, Suite # 402 March 15, 2017 Woodbridge, Ontario, L4L 8K8, Canada. Submission Control No: 203516 _Page 2 of 42 _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ........................................ 3 SUMMARY PRODUCT INFORMATION .......................................................... 3 INDICATIONS AND CLINICAL USE ................................................................ 3 CONTRAINDICATION ........................................................................................ 4 WARNINGS AND PRECAUTIONS .................................................................... 4 ADVERSE REACTIONS ...................................................................................... 8 DRUG INTERACTIONS .................................................................................... 15 DOSAGE AND ADMINISTRATION ................................................................ 17 OVERDOSAGE .................................................................................................. 18 ACTION AND CLINICAL PHARMACOLOGY .............................................. 18 STORAGE AND STABILITY ............................................................................ 19 SPECIAL HANDLING INSTRUCTION………………………………………20 DOSAGE FORMS, COMPOSITION AND PACKAGING ............................... 20 PART II: SCIENTIFIC INFORMATION ................................................................ 21 PHARMACEUTICAL INFORMATION ............................................................ 21 CLINICAL TRIALS ............................................................................................ 22 DETAILED PHARMACOLOGY ....................................................................... 25 MICROBIOLOGY ......................................................................................... Կարդացեք ամբողջական փաստաթուղթը